In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

During a Case-Based Roundtable® event, Kathryn E. Beckermann, MD, PhD, discussed second-line regimens with event participants ...

In patients with advanced clear cell renal cell carcinoma (ccRCC), sitravatinib (tyrosine kinase inhibitor) has shown efficacy both alone and in combination with nivolumab (anti-PD-1). Here ...

Skin cancer is by far the most common type of cancer in the United States. Merkel cell carcinoma (MCC) is a type of skin cancer, but it's not common. About 3,000 people are diagnosed with Merkel cell ...

Background: Cytotoxic chemotherapy has not been well investigated in non-clear-cell renal cell carcinoma (RCC ... papillary and 1 had collecting duct histology. The patient with collecting ...

Purpose. The diagnosis, staging, and management of renal cell carcinoma (RCC) are reviewed. The mechanism, pharmacokinetics, toxicity, clinical activity, and application of molecularly targeted ...

Another structure called a tubule removes waste products and returns important substances to your bloodstream. Because renal cell carcinoma is the most common type, most of the information below ...

Aggressive forms of kidney cancer may be more challenging to treat and cure than other types. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is thought to be one of the most aggressive ...

Renal cell carcinoma is the most common type of kidney cancer, representing 90% of kidney cancer diagnoses, and the deadliest urological cancer. While the incidence and mortality rates by renal cell ...

1Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio. Search for other works by this author on: 2Department of Biostatistics, Health Informatics and Data ...

Our objective was to develop an automated process using convolutional neural networks (CNNs) to extract and structure biomedical insights from electronic health reports (EHRs) in a large thyroid ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with kidney cancer commonly have trouble affording ...